sander, auteur op Vanishing White Matter Consortium

Guanabenz VWM clinical trial patient enrollment has started

We are pleased to announce that the first three VWM patients have been enrolled in the study and more patients will follow soon.

First VWM consortium presentation at ULF family conference – June 25th 2021

This conference focuses on providing scientific information to keep families informed of progress in the leukodystrophy field. Please join our presentation live.

VWM mouse models through the CRO Sylics

Amsterdam UMC developed two mouse models for VWM. These mice harbor VWM genetic mutations, which result in a phenotype similar to human VWM patients.